Tools
Stock profile

UNITEDHEALTH GROUP INC (UNH)

UNH · Latest close $349.91 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$349.91
As of Nov 18, 2026
Tracked funds holding
30 of 149
2026 Q2 13F filings
Opened / added
6 / 9
vs previous quarter
Trimmed / exited
18
vs previous quarter

UNITEDHEALTH GROUP INC (UNH) is held by 30 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 6 funds opening new positions, 9 funds adding, and 18 funds trimming or exiting versus the previous quarter. Insiders were net sellers over the last 90 days ($0 bought vs $455.9K sold). 3 members of Congress reported 4 purchases vs 8 sales. Latest close $349.91 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Aug 21, 2026 · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Insiders · 90d
net $-455.9K
Congress
4 buys vs 8 sales
Fundamentals
Revenue · FY2025
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Government relations · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Veritas Asset Management · Eagle Capital Management · Patient Capital Management — 30 tracked funds hold UNH. See all holders.

Insider and Congress activity

Insiders bought on the open market (0 purchases, $0) vs 1 sale ($455.9K). Insider trading 3 members of Congress reported buying (4 purchases vs 8 sales). Latest buy: Jun 4, 2026. Politician trading

Often held alongside

SS SPDR BB 1-3M T-BILL ETF (BIL) · DONALDSON Co INC (DCI) · GENERAL MILLS INC (GIS) · ARTIVION, INC. (AORT) · Chime Financial, Inc. (CHYM) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Veritas Asset Management8.06%1,078,201TRIMMED (-42.7%) Q3 filed Nov 5
Eagle Capital Management7.33%5,773,026TRIMMED (-1.5%) Q3 filed Nov 16
Patient Capital Management5.96%437,773ADDED (+0.1%) Q3 filed Nov 12
Longview Partners (Guernsey)5.69%842,497TRIMMED (-24.9%) Q3 filed Nov 13
Ruane Cunniff LP4.56%705,554TRIMMED (-3.1%) Q3 filed Nov 16
Sanders Capital2.46%5,898,634TRIMMED (-1.1%) Q3 filed Nov 2
Century Management2.43%27,680TRIMMED (-4.2%) Q3 filed Nov 16
Mondrian Investment Partners2.38%370,657ADDED (+7.2%) Q3 filed Oct 23
Davis Advisors2.28%1,274,650ADDED (+2.2%) Q3 filed Nov 10
Atalanta Sosnoff Capital2.15%293,390ADDED (+183.1%) Q3 filed Nov 10

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: -8.6% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

610.79222.852024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

412016Q3: 23 funds2016Q4: 26 funds2017Q1: 26 funds2017Q2: 28 funds2017Q3: 25 funds2017Q4: 30 funds2018Q1: 29 funds2018Q2: 30 funds2018Q3: 28 funds2018Q4: 27 funds2019Q1: 29 funds2019Q2: 28 funds2019Q3: 28 funds2019Q4: 34 funds2020Q1: 30 funds2020Q2: 31 funds2020Q3: 31 funds2020Q4: 37 funds2021Q1: 37 funds2021Q2: 39 funds2021Q3: 40 funds2021Q4: 37 funds2022Q1: 38 funds2022Q2: 36 funds2022Q3: 37 funds2022Q4: 39 funds2023Q1: 37 funds2023Q2: 37 funds2023Q3: 37 funds2023Q4: 37 funds2024Q1: 38 funds2024Q2: 39 funds2024Q3: 39 funds2024Q4: 41 funds2025Q1: 36 funds2025Q2: 32 funds2025Q3: 33 funds2025Q4: 32 funds2026Q1: 27 funds2026Q2: 30 funds2016Q32026Q2

Tracked funds holding this stock, by quarter (2016Q3–2026Q2, 40 quarters). Source: quarterly BEST lists from 13F filings — tracked funds only, not all filers. A stock appears here only if it ever made a quarterly BEST list.

All institutions · Form 13F

Institutions holding3,391 of 8,857 filers
Long-only filers among them3,373
Change vs 2026 Q1+384 net · 2,177 entered · 1,793 exited
Shares reported, all filers779,409,610
Reported value, all filers$336.8B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNYSE
IndustryHospital & Medical Service Plans (SIC 6324)
Revenue · FY2025$447.6B
Net income · FY2025$12.1B
Total assets · FY2025$309.6B
Shares outstanding897,594,847
Market cap (at latest close)$314.1B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Jul 31, 2026.

Short interest

Shares short · Oct 15, 202614,007,404
Share of shares outstanding1.56%
Days to cover2.05

Shares short at recent settlements — Jul 31, 2026: 15.1M · Aug 14, 2026: 15.5M · Aug 31, 2026: 15.3M · Sep 15, 2026: 13.2M · Sep 30, 2026: 16.0M · Oct 15, 2026: 14.0M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Jul 31, 2026.

Fails to deliver

Shares failed to deliver · Oct 14, 20260
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 20260.0%

Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 162 · Oct 14, 2026: 0.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Jul 31, 2026.

Insider trading · Form 4

0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 1 sale by 1 insider ($455.9K).

Source: SEC Form 4 filings. Open-market transactions only.

Recent open-market trades

DateInsiderRoleBuy / SellSharesPriceValueSource
Aug 21, 2026Conway Patrick HughChief Executive Officer, OptumSell1,169$390.00$455.9KSEC filing

Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Aug 21, 2026Conway Patrick HughOfficer1,169$455.9KAug 21, 2026SEC filing
Aug 5, 2026Conway Patrick HughOfficer500$205.0KAug 5, 2026SEC filing
Apr 23, 2026Conway Patrick HughOfficer800$284.0KApr 23, 2026SEC filing
Sep 11, 2025James P Schadt Trust FBO Lauren C S Baker UAD 12-16-15Affiliate27$9.4KSep 11, 2025SEC filing
Jun 10, 2025Conway Patrick HughOfficer589$179.6KJun 10, 2025SEC filing
Nov 12, 2024McSweeney ErinOfficer701$439.0KNov 11, 2024SEC filing
Jul 18, 2024McSweeney ErinOfficer1,500$868.5KJul 18, 2024SEC filing
Jul 17, 2024ROOS THOMAS EOfficer2,851$1.6MJul 17, 2024SEC filing
Mar 8, 2024McSweeney ErinOfficer1,237$597.6KMar 8, 2024SEC filing
Feb 23, 2024ROOS THOMAS EOfficer858$451.1KFeb 23, 2024SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Aug 7, 2026STATE STREET CORPORATIONSC 13G45,684,4125.0%Jun 30, 2026SEC filing
Apr 30, 2026Vanguard Capital ManagementSC 13G68,122,4837.5%Mar 31, 2026SEC filing
Mar 27, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
May 7, 2025The Vanguard GroupSC 13G/A91,802,96010.1%Apr 30, 2025SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

3 members of Congress reported buying (4 purchases vs 8 sales). Bought by Democrats and Republicans. Latest buy: Jun 4, 2026.

Source: U.S. House Clerk and U.S. Senate eFD STOCK Act periodic transaction reports, as of Nov 16, 2026. Reported amounts are ranges, and reports can arrive up to 45 days after the trade.

Recent activity by member

MemberChamberPartyBuysSellsLatestAmount range
Salazar, Maria ElviraHouseR22Sep 24, 2026$1,001 - $15,000
Hern, KevinHouseR02Sep 23, 2026$15,001 - $50,000
McCormick, Richard DeanHouseR03Jul 30, 2026$1,001 - $15,000
Newhouse, DanHouseR01Jul 10, 2026$1,001 - $15,000
Boozman, JohnSenateR10Jun 4, 2026$1,001 - 15,000
Cisneros, GilbertHouseD10Apr 14, 2026$1,001 - $15,000

Member-level activity in the current window, most recent first (House data to Nov 16, 2026, Senate to Oct 1, 2026). House reports arrive as PDFs without transaction-level rows in the current corpus, so this table shows per-member totals, not individual trades; the member page lists the underlying filings. Senate rows link the same way — the member page carries the eFD filing links.

Committee jurisdiction

Industry: Hospital & Medical Service Plans (SIC 6324). Standing committees with jurisdiction over this industry: House Committee on Financial Services, Senate Committee on Banking, Housing, and Urban Affairs.

Member who traded this stockSits on
Salazar, Maria ElviraHouse Committee on Financial Services

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Government relations

Lobbying: 667 Lobbying Disclosure Act filings named this company as client, 1999–2026; most common issues: Health Issues (538), Medicare/Medicaid (408), Insurance (127).

Federal contracts: $78.5B in obligated amounts, fiscal years 2021–2026.

Fiscal yearObligated amount
FY2021$9.9B
FY2022$1.1B
FY2023$876.5M
FY2024$18.8B
FY2025$25.4B
FY2026$22.5B

Largest awards collected

Award IDAgencyAmountStart
HT940212C0001Department of Defense$13.1BMar 20, 2012
HT001119F0049Department of Defense$45.8MJun 3, 2019
HT001118F0029Department of Defense$45.5MJun 14, 2018
36C10G20F0001Department of Veterans Affairs$38.2MOct 15, 2019
HT001119F0082Department of Defense$37.6MSep 4, 2019

Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.

Screens & lenses

Politicians

· Bought by Members — Last 6 months: bought by a member of the U.S. Congress

· Bought by Both Parties — Last 6 months: bought by both Democratic and Republican members

· Bought by 3+ Members — Last 6 months: bought by 3 or more different members

Financial Screens

· Buffett — Companies with high ROE sustained for more than a decade

· Growth — Revenue up every year for 5 straight years

· Dividend Growth — Dividends raised for more than 10 years

· Earnings Quality (Cash Conversion) — Profits that actually come back as cash

· Shareholder Yield — Cash returned through dividends and buybacks

· Earnings Stability — Small earnings swings and almost no loss years

Key figures

· Buffett — Latest ROE: 12.0% · Years ROE ≥15% (of 10): 8 · 10-yr avg ROE: 20.5% · Latest net income: $12.1B

· Growth — Latest revenue: $447.6B · 5-yr revenue CAGR: 11.7% · Straight growth years: 18

· Dividend Growth — Dividend per share: 8.73 · Dividend yield: 2.1% · Straight dividend years: 19 · 10-yr dividend growth: 267.6%

· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 1.54 · Operating cash flow: $19.7B · Net income: $12.1B

· Shareholder Yield — Shareholder yield: 3.6% · of which dividends: 2.1% · of which buybacks: 1.5%

· Earnings Stability — Earnings variation (CV): 0.30 · Loss years (of 10): 0 · Latest net income: $12.1B

· Bought by Members — Members buying: 3 · Buy txns: 4 · Sell txns: 8 · Latest buy: Jun 4, 2026

· Bought by Both Parties — Members buying: 3 · Buy txns: 4 · Sell txns: 8 · Latest buy: Jun 4, 2026

· Bought by 3+ Members — Members buying: 3 · Buy txns: 4 · Sell txns: 8 · Latest buy: Jun 4, 2026

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

· Super-investor 13F BEST — appeared in 40 of the last 40 quarterly lists; latest 2026 Q2, ranked #14 of 50.

· Insider BEST — appeared in 1 of the last 20 quarterly lists; latest 2025 Q2, ranked #10 of 50.

· Politician BEST — appeared in 15 of the last 20 quarterly lists; latest 2026 Q2, ranked #26 of 50.

13F signal (2021 Q3 – 2026 Q1)EventsWin rateAvg returnSPYExcess
Heavy accumulation — 3+ tracked funds increased together1560.0%+3.4%+2.9%+0.5%
Share count tripled (3x)475.0%+3.2%+4.5%-1.3%
Heavy exit — 3+ tracked funds sold out together560.0%-0.8%+2.6%-3.5%

Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.

Also held by the tracked funds that hold UNH — ranked by lift, the co-holding pattern described in Methodology: SS SPDR BB 1-3M T-BILL ETF (BIL) · DONALDSON Co INC (DCI) · GENERAL MILLS INC (GIS) · ARTIVION, INC. (AORT) · Chime Financial, Inc. (CHYM) · DuPont de Nemours, Inc. (DD) · GOLD FIELDS LTD (GFI) · INTERNATIONAL PAPER CO /NEW/ (IP).

Filings audit: every filing lens on UNITEDHEALTH GROUP INC (UNH), scored — GetCoattail Research.

Recent 8-K filings

FiledItemsSource
Nov 9, 20265.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain OfficersSEC filing
Oct 13, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Sep 8, 20267.01 Regulation FD DisclosureSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

SS SPDR BB 1-3M T-BILL ETF (BIL) · Filings audit: every filing lens on UNITEDHEALTH GROUP INC (UNH), scored · Practice timing on UNH

One email a week: the week’s new filings and research. Subscribe free

← UNFI  ·  UNIT →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.